To DE-obligate remaining 2017 funds.

Ended Awarded Last action

Contract number
HHSN27200004
Awardee
Awarding agency
Obligated
$432,452

Award facts

Opportunity
  • NIHAI2014013 Solicitation number
Contract value 100% obligated
$432,452.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
New York, NY 10004, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$17,967
Other Administrative Action 1 $0
Original award Feasibility assessment of HIV ENV protein antigens $450,419

About this award

The National Institute of Allergy and Infectious Diseases issued a delivery order to International AIDS Vaccine Initiative Inc. on September 14, 2017, with a ceiling value of $432,452.00 for a feasibility assessment of HIV envelope protein antigens to de-obligate remaining 2017 funds.

Place of performance is New York, NY. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of October 31, 2018. No set-aside was used.

Quick answers

Who was awarded contract HHSN27200004?

HHSN27200004 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 14, 2017.

How much is contract HHSN27200004 worth?

The government has obligated $432,452 on HHSN27200004.

Is contract HHSN27200004 an order under another contract?

Yes. HHSN27200004 is a delivery order under HHSN272201600011I, an indefinite delivery contract.

Was contract HHSN27200004 competed?

The extent of competition for HHSN27200004 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award